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Abstract 
The identity of the physiologically relevant metal ions for the methionyl aminopeptidase (MetAP) 
from Escherichia coli was investigated and is suggested to be Fe(II). The metal content of whole cells in the 
absence and presence of expression of the type I MetAP from E. coli was determined by inductively coupled 
plasma (ICP) emission analysis. The observed change in whole cell concentrations of cobalt, cadmium, copper, 
nickel, strontium, titanium, and vanadium upon expression of MetAP was negligible. On the other hand, 
significant increases in the cellular metal ion concentrations of chromium, zinc, manganese, and iron were 
observed with the increase in iron concentration being 4.4 and 6.2 times greater than that of manganese and 
zinc, respectively. Activity assays of freshly lysed BL21(DE3) cells containing the pMetAAP plasmid revealed 
detectable levels (>2 units/mg) of MetAP activity. Control experiments with BL21(DE3) without the MetAP 
plasmid showed no detectable enzymatic activity. Since MetAP is active upon expression, these data strongly 
suggest that cobalt is not the in vivo metal ion for the MetAP from E. coli. The MetAP from E. coli as purified was 
found to be catalytically inactive (≤2 units/mg). ICP emission analysis of the as-purified enzyme revealed no 
catalytically relevant metal ions. Both the Co(II)− and Fe(II)−MetAP enzymes are susceptible to autoxidation, so 
strict care must be taken to remove all dissolved oxygen. Enzymatic assays performed under anaerobic 
conditions indicated that of the di- and trivalent metal cations tested to date, only Co(II) (37.3 units/mg), Fe(II) 
(29.7 units/mg), Mn(II) (7.0 units/mg), and Zn(II) (3.3 units/mg) provided detectable levels of enzymatic activity. 
In each case, excess metal ions were found to be inhibitory. The observed specific activity of Co(II)−MetAP is 
more than 3 times greater than that previously reported for the MetAP from E. coli [Ben-Bassat, A., et al. 
(1987) J. Bacteriol.169, 751−757]. This increase in activity is likely due to the strict exclusion of air from reaction 
samples. Oxidation of either the Fe(II) or Co(II) form of the enzyme resulted in the complete loss of catalytic 
activity. The substrate binding constants (Km) for Met-Gly-Met-Met binding to the Co(II)- or Fe(II)-substituted 
MetAP enzymes, under anaerobic conditions, were found to be 3.16 and 1.95 mM, respectively. The 
combination of these data suggests that the in vivo metal ions for the MetAP enzyme from E. coli are likely Fe(II) 
ions. 
 
In the cytosol of eukaryotes, the translation of all proteins is initiated with an N-terminal methionine residue, 
whereas in prokaryotes, mitochondria, and chloroplasts, translation of proteins is initiated with an N-
formylmethionine (1−4). The N-formyl group is typically removed cotranslationally by a deformylase that leaves 
the N-terminal methionine with a free NH2 group (2). In both eukaryotic and prokaryotic cells, methionyl 
aminopeptidases (MetAPs)1 selectively cleave methionine residues from the N-termini of polypeptide chains (5). 
Removal of methionine is essential for protein maturation as well as for the post-translational modification of 
the N-termini of proteins, such as N-acetylation or N-myristoylation (2). The compositions of mature N-termini 
play important roles in the directed degradation and cellular targeting of proteins (1, 3, 4). Examples include 
hemoglobin as well as proteins involved in signal transduction, protein trafficking, cancer cell growth, and both 
bacterial and viral infections (6, 7). Deletion of the gene encoding MetAP is lethal to Escherichia coli, Salmonella 
typhimurium, and Saccharomyces cerevisiae; therefore, MetAPs are essential for cell growth and proliferation 
(8−10). The importance of understanding the mechanism of action of MetAPs is underscored by the recent 
observation that MetAPs are the target for the anti-angiogenesis drugs ovalicin and fumagillin (11−15). 
Therefore, the inhibition of methionyl aminopeptidase activity in malignant tumors is critically important in 
preventing tumor vasculature formation and, thus, the growth and proliferation of carcinoma cells. 
Several MetAPs have been purified and sequenced from a variety of bacterial and mammalian sources, including 
humans (16−22). The enzymes from E. coli, S. cerevisiae, Sa. typhimurium, Pyrococcus furiosus, porcine liver, 
and humans have been the most extensively studied. Three MetAPs have been crystallographically 
characterized, and all three have a central antiparallel pleated β-sheet flanked by two α-helical segments 
(15, 23, 24). The MetAP from E. coli contains an internal pseudo-2-fold symmetry that relates both halves of the 
molecule to one another from a structural standpoint. This symmetry is lost for the P. furiosus and human 
enzymes due to a 62-amino acid insert, which distinguishes type II MetAPs from type I MetAPs (3). At this time, 
the functional role of this 62-amino acid insert remains unknown, but the homologous relationship between all 
MetAPs has been suggested to indicate an evolutionary separation of considerable distance (3). A dinuclear 
cobalt active site is located at roughly the center of the molecule in the concave face of the β-pleated sheet. The 
two cobalt ions in each of the three structurally characterized MetAPs contain identical ligands that are made up 
of side chain Asp, Glu, and His residues (Figure 1). The two cobalt ions reside in a distorted five-coordinate 
environment in the human and P. furiosus structures but were reported to be five- and six-coordinate in the E. 
coli structure (15, 23−25). The P. furiosus and E. coli structures revealed a bridging water/hydroxide group, 
whereas the human enzyme exhibits only a terminal water/hydroxide molecule on the Co1 center. This 
difference in terminal water/hydroxide versus bridging water/hydroxide may be the result of variations in pH 
during crystallization conditions. 
 
Figure 1 Schematic representations of the dinuclear cobalt active sites of the three crystallographically 
characterized methionyl aminopeptidases. 
 
All of the purified and sequenced MetAPs from prokaryotes, eukaryotes, and archaebacteria exhibit strict 
catalytic specificity for methionine and exhibit an identical metal binding motif (3, 5). Moreover, each of the 
MetAPs purified to date is inactivated by the addition of complexing agents such as EDTA and 1,10-
phenanthroline, establishing the necessity for divalent metal ions in catalysis. However, none of these enzymes 
have been screened for their native metal ion content, and therefore, the in vivo metal ions remain unknown. In 
an effort to identify the in vivo metal ions for MetAPs, we have examined the metal content of whole cells with 
and without the expression of the type I MetAP from E. coli. We have also re-examined the levels of MetAP 
activity observed under anaerobic conditions, with various di- and trivalent metal ions, including Mg(II), Mn(II), 
Fe(II), Fe(III), Co(II), Co(III), Ni(II), Zn(II), and Cd(II). The substrate (Met-Gly-Met-Met) binding constants for both 
the Co(II)- and Fe(II)-substituted MetAP enzymes were also determined under anaerobic conditions. The 
combination of these data suggest that the in vivo metal ions for the MetAP enzyme from E. coli are likely Fe(II). 
Materials and Methods 
Enzyme Purification.  
All reagents used in this study were purchased commercially and were of the highest quality available. 
Recombinant E. coli MetAP was purified from a stock culture kindly provided by B. W. Matthews and W. T. 
Lowther (14). MetAP was purified according to the previously published protocol with minor modifications (14). 
Briefly, 5 L fermentation cultures of E. coli BL21(DE3) (pMetAAP) in LB-Kanamycin broth were grown. The 
temperature was maintained at 37 °C until an OD600 of 1.0 was reached, upon which the temperature was 
decreased to 30 °C and overexpression of MetAP was induced by the addition of 1 mM isopropyl β-d-
thiogalactoside (IPTG). After 3 h, the cells were harvested by centrifugation and resuspended in 100 mL of +T/G 
buffer [50 mM Hepes (pH 7.9), 10% glycerol, 0.1% Triton X-100, and 0.5 M KCl], 4 mg of DNase, 100 μL of 1 M 
MgCl2, 1 mL of 100 mM PMSF, and 0.22 g of methionine. The cells were then lysed with a French press and 
centrifuged at 18 000 rpm for 45 min. The resulting solution was filtered through a 0.45 μm filter and loaded 
onto a 10 mL NTA−agarose column that had been equilibrated with +T/G buffer. After extensive washing with 
+T/G buffer followed by −T/G buffer (same as +T/G but without Triton X-100 and glycerol), MetAP was eluted 
with −T/G buffer containing 60 mM imidazole. The active fractions were pooled, and EDTA was added 
immediately to a concentration of 5 mM. MetAP was then dialyzed against three changes of 25 mM Hepes 
buffer (pH 7.9) containing 150 mM KCl and 15 mM methionine at 4 °C that had been passed through a Chelex-
100 column to remove any trace metals. Aggregation of protein was observed with the use of nonchelexed 
buffer. At this point, MetAP is pure as determined by SDS−polyacrylamide gel electrophoresis. 
Removal of the His tag from MetAP was accomplished by incubation of 100 mg aliquots with 0.125 unit/mg 
biotinylated thrombin at 15 °C for 18−20 h. This mixture was then filtered through a 0.45 μm filter and loaded 
onto a 10 mL NTA−agarose column that had been pre-equilibrated with −T/G buffer. The resulting MetAP-
containing fractions were pooled and concentrated to 1.5−2 mL and loaded onto a pre-equilibrated [25 mM 
Hepes (pH 7.5), 150 mM KCl, and 15 mM methionine] Superdex 75 Hi-load prep-grade 16/60 gel filtration 
column. Removal of the poly-His tail was confirmed by matrix-assisted laser desorption ionization-time-of-flight 
(MALDI-TOF) mass spectroscopy. Via elimination of any divalent metal ions in the last column step, apo-MetAP 
was obtained as shown by inductively coupled plasma (ICP) emission analysis. The protein was washed free of 
methionine using chelexed methionine-free buffer [25 mM Hepes (pH 7.5) and 150 mM KCl] prior to all kinetic 
assays. Samples of MetAP were routinely concentrated by microfiltration using a Microcon-10 concentrator 
(Millipore Corp.) and stored in liquid nitrogen until they were needed. 
Protein concentrations were determined by the absorption at 280 nm using an extinction coefficient of 16 445 
M-1 cm-1. This value was determined by the Edelhoch method using a 1:8:7 molar ratio mixture of N-acetyl-l-
tryptophanamide, Gly-Tyr-amide, and l-cysteine to model MetAP (26, 27). The molar absorptivity determined 
from this method (ε280 = 16 445 M-1 cm-1) for MetAP solubilized in 6 M guanidine hydrochloride is in good 
agreement (ε280 = 16 350 M-1 cm-1) with that reported by Lowther et al. (14). All electronic absorption spectra 
were recorded on a Shimadzu UV-3101 PC spectrophotometer equipped with a constant-temperature cell 
holder and a Haake (type 423) constant-temperature circulating bath. 
Preparation of Cell Extracts for ICP Metal Analysis.  
All glassware that was used was soaked in concentrated nitric acid and rinsed in chelexed nanopure water. 
Three 250 mL cultures of BL21(DE3) cells containing the expression plasmid for E. coli MetAP were grown in 
Luria-Bertani broth with kanamycin (50 mg/L) at 30 °C in a shaker. Overexpression of MetAP was induced by the 
addition of IPTG to a concentration of 1 mM at an OD600 of 1.0. The cells were grown at 25 °C for 3 h and 
harvested by centrifugation at 8000 rpm for 15 min. These cells were washed extensively with buffer [25 mM 
Hepes (pH 7.5) and 150 mM KCl]. Overexpression of MetAP was verified by SDS−PAGE. Three control 
experiments with BL21(DE3) cells without the expression plasmid were also carried out under identical 
conditions and the cells extensively washed with buffer. Cells (0.5 g wet weight) from each flask were 
resuspended in 5 mL of buffer [25 mM Hepes (pH 7.5) and 150 mM KCl]. Following the addition of 4 mM 
phenylmethanesulfonyl fluoride (PMSF) and 2 mg of lysozyme to each sample, the cell suspensions were 
incubated at 4 °C for 3 h. The cells were lysed by sonication (Heat Systems-Ultrasonics, Inc., three pulses with a 
duration of 30 s at 5 min intervals) and the lysates centrifuged at 14 000 rpm for 45 min. Concentrated nitric acid 
was added to the supernatants to a final concentration of 1 M and the mixture left for overnight digestion. The 
flocculent precipitates were removed by microfuging at 14 000 rpm for 15 min and the supernatants diluted 1:5 
in chelexed nanopure water. Concentrations of metal ions were determined by inductively coupled plasma (ICP) 
emission analysis. The buffer used for resuspension of cell cultures was also shown to be metal free by ICP metal 
analysis. Three cell cultures of MetAP cells not bearing the vector carrying the gene for MetAP, carrying the 
vector but not overexpressing MetAP, and carrying the vector which were subsequently induced to overexpress 
MetAP were grown in Minimal Media to which 1 μM CoCl2 had been added. After identical workup, ICP analysis 
indicated that no cobalt uptake was observed, thus indicating that cobalt is not limiting in our experiments. 
Enzymatic Assay of MetAP.  
MetAP was assayed using the tetrapeptide substrate Met-Gly-Met-Met and an HPLC system (Shimadzu LC-10A 
Class-VP5) with a C8 column (Phenomenex, Luna; 5 μm, 4.6 mm × 25 cm) to directly detect the product of 
hydrolysis Gly-Met-Met. All assays were performed under strict anaerobic conditions in an inert atmosphere 
glovebox in a dry bath incubator maintained at 30 °C. All substrate stock solutions were prepared anaerobically 
in buffer [25 mM Hepes (pH 7.5) and 150 mM KCl] to eliminate oxidation of the methionine component of the 
substrate. Metal insertion in apo-MetAP was effected by the addition of 3 equiv of a divalent metal chloride salt 
to 20 μM enzyme, where the divalent metal ion was Co, Fe, Ni, Zn, Cd, or Mn (≥99.999% pure, Strem Chemicals, 
Newburyport, MA, or Aldrich) followed by a 30 min incubation period at 30 °C. A typical assay involved the 
addition of 4 μL of M(II)−MetAP to a 16 μL reaction mixture which contained 8 mM substrate in 25 mM Hepes 
(pH 7.5) and 150 mM KCl and was incubated at 30 °C for 1 min. The reaction was quenched by the addition of 20 
μL of a 0.1% trifluoroacetic acid solution. The reaction mixture was filtered through a 0.2 μm filter, and 10 μL 
samples were applied to a reverse-phase HPLC C8 column. The eluting solvents were as follows:  (i) mobile phase 
A being 98% water, 2% acetonitrile, and 0.1% trifluoroacetic acid and (ii) mobile phase B being 100% acetonitrile 
and 0.1% trifluroacetic acid. The applied sample was resolved into substrate and product peaks during a 15 min 
run of mobile phase A at a flow rate of 1.5 mL/min. Mobile phase B was then used to elute any residual material 
before returning to initial conditions. The kinetic parameters v (velocity) and Km (Michaelis constant) were 
determined at pH 7.5 by quantifying the tripeptide Gly-Met-Met at 215 nm in triplicate. One unit was defined as 
the amount of enzyme that releases 1 μmol of Gly-Met-Met at 30 °C in 1 min. 
Results 
Whole Cell Metal Analyses.  
To determine which metal ions are potentially the in vivo metal ions for the MetAP from E. coli, cell paste 
samples were collected both before and after the induction of MetAP synthesis. After collection, the cells were 
washed extensively with buffer, lysed, and digested with nitric acid. Once the cell debris was removed, the 
supernatant was subjected to metal analysis using ICP emission spectroscopy. Since MetAP is expressed at high 
levels after induction (Figure 2), comparison of the whole cell metal concentrations in the presence and absence 
of MetAP expression should reflect the metal ion content of MetAP (Table 1). The observed changes in whole 
cell concentrations of cobalt, cadmium, copper, nickel, strontium, titanium, and vanadium upon expression of 
MetAP were negligible. On the other hand, detectable increases in the cellular metal ion concentrations of 
chromium, zinc, manganese, and iron were observed with the increase in iron concentration being 4.4 and 6.2 
times greater than that of manganese and zinc, respectively. Activity assays of freshly lysed BL21(DE3) cells 
containing the pMetAAP plasmid revealed detectable levels of MetAP activity. Control experiments with 
BL21(DE3) cells without the MetAP plasmid had no detectable enzymatic activity. 
 
Figure 2 SDS−polyacrylamide gel of (lane 1) BL21(DE3) cells, without the plasmid (pMetAAP) that contains the 
MetAP gene, 3 h after induction with IPTG, (lane 2) BL21(DE3) cells containing the pMetAAP plasmid that 
contains the MetAP gene, 3 h after induction with IPTG, and (lane 3) purified MetAP from E. coli. The molecular 
weight of the MetAP from E. coli was found to be 29 630 using matrix-assisted laser desorption ionization time-
of-flight mass spectroscopy. 
 
Table 1:  Total Metal Ion Concentrations of Whole Cells before and after Overexpression of the Methionyl 









Cd 0.00 0.00 0.00 
Co 0.00 0.00 0.00 
Cr 0.22 0.35 0.13 
Cu 0.15 0.13 −0.02 
Fe 0.42 0.90 0.48 
Mn 0.09 0.20 0.11 
Ni 0.03 0.01 −0.02 
Sr 0.00 0.01 0.01 
Ti 0.00 0.00 0.00 
V 0.03 0.04 0.01 
Zn 0.58 0.66 0.08 
a Values are the average of three individual experiments. Each value has an experimental error of ±0.06. 
Activation of MetAP by Divalent Metal Ions.  
The MetAP from E. coli as purified was found to be catalytically inactive (≤2 units/mg). ICP emission analysis of 
the as-purified enzyme revealed no catalytically relevant metal ions. Therefore, MetAP as purified is in the apo 
form, which is likely the consequence of incubation with EDTA during the initial stages of purification. Matrix-
assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectroscopy provided a molecular weight 
of 29 633 ± 2.9 for apo-MetAP. This molecular weight corresponds to the MetAP enzyme and the four amino 
acid residues (Leu-Val-Pro-Arg) which are attached to the C-terminus prior to the engineered thrombin cleavage 
site and six-histidine tail (14). In a similar experiment, the molecular weight of the poly-His-MetAP enzyme was 
determined and found to be 30 869.7 ± 2.5. The molecular weight difference of 1236.4 ± 2.7 corresponds to the 
four amino acid residues (Gly-Ser-Leu-Glu) to the C-terminal side of the thrombin cleavage site and the six-
histidine tail. The molecular weight of 29 633 for the MetAP from E. coli determined by mass spectroscopy is in 
excellent agreement (29 630 and 29 333) with those previously reported for the MetAP from E. coli (14, 17). 
Strict care must be taken to remove all dissolved oxygen from MetAP samples in the presence of Co(II) or Fe(II) 
since the coordinated divalent metal ions are susceptible to autoxidation. To ensure homogeneous enzyme 
solutions, each metal-substituted MetAP sample was prepared under anaerobic conditions by adding 3 equiv of 
MCl2 salts to apo-MetAP, followed by incubation for 30 min at 30 °C. Only 3 equiv of metal ion was used because 
excess metal was found to be inhibitory. To determine the activity of the Co(III)− and Fe(III)−MetAP enzymes, 
the divalent metal-containing enzyme samples were allowed to sit in air for several days and minutes, 
respectively, at pH 7.5. Alternatively, Co(II)-substituted MetAP was treated with 1 mM hydrogen peroxide to 
effect the conversion of Co(II) to Co(III). Prior to activity measurements, the hydrogen peroxide-treated enzyme 
was washed extensively with 25 mM Hepes (pH 7.5), 150 KCl buffer. Oxidation of Fe(II)−MetAP to Fe(III)−MetAP 
was confirmed by EPR spectroscopy. 
We have re-examined the levels of MetAP activity in the presence of several different metal ions under 
anaerobic conditions. To date, we have tested MetAP with Mg(II), Mn(II), Fe(II), Fe(III), Co(II), Co(III), Ni(II), Zn(II), 
and Cd(II) (Table 2). Of the di- and trivalent cations that were tested, only Co(II) (37.3 units/mg), Fe(II) (29.7 
units/mg), Mn(II) (7.0 units/mg), and Zn(II) (3.3 units/mg) provided detectable levels of enzymatic activity (Table 
2). The reaction time of 1 min used for all activity assays is well within the linear region of the progress curve, 
indicating that under our reaction conditions, we are in the steady state regime (Figure 3). The observed activity 
level for Co(II)−MetAP is more than 3 times higher than that previously reported for the MetAP from E. coli (17). 
This increase in activity is likely due to the strict exclusion of air from reaction samples. Interestingly, 
Fe(II)−MetAP provides a MetAP enzyme that is ∼80% as active as the Co(II)-substituted form of MetAP, while 
Zn(II)-substituted MetAP exhibits activity levels ∼10-fold lower than those of Co(II)− or Fe(II)−MetAP. Activity 
measurements performed under anaerobic conditions in the presence of reduced glutathione (5 mM), which 
mimics the conditions of the cellular cytoplasmic space, showed no detectable change in activity for Co(II)−, 
Fe(II)−, or Zn(II)−MetAP. In these experiments, apo-MetAP was incubated with 5 mM glutathione for 30 min at 
30 °C followed by the addition of 3 equiv of divalent metal ion and incubation for an additional 30 min at 30 °C. 
For each catalytically active metal-substituted MetAP sample, ICP emission analysis was performed to establish 
the metal content of the sample. In all cases, no detectable metal ion impurities were observed. 
 
Figure 3 Plot of the rate of product formation vs time (minutes). Co(II)−MetAP was assayed using the 
tetrapeptide substrate Met-Gly-Met-Met and an HPLC system equipped with a C8 column to directly detect the 
product of hydrolysis, Gly-Met-Met. All assays were performed under strict anaerobic conditions in an inert 
atmosphere glovebox in a dry bath incubator maintained at 30 °C. All enzyme and substrate stock solutions were 
prepared anaerobically in 25 mM Hepes buffer (pH 7.5) containing 150 mM KCl. 
 
Table 2:  Specific and Relative Activities of the MetAP from E. coli with Various Divalent Cations 
metal ion specific activitya (units/mg) relative activity (%) 
none ≤2 ≤5 
Mg2+ ≤2 ≤5 
Mn2+ 7.0 ± 2 19 
Fe2+ 27.5 ± 3 74 
Fe2+ and GSHb 29.7 ± 3 80 
Fe3+ ≤2 ≤5 
Co2+ 36.9 ± 3 99 
Co2+ and GSHb 37.3 ± 3 100 
Co3+ ≤2 ≤5 
Ni2+ ≤2 ≤5 
Zn2+ 2.3 ± 2 6 
Zn2+ and GSHb 3.3 ± 2 9 
Cd2+ ≤2 ≤5 
a One unit of activity equals 1 μmol of tripeptide Gly-Met-Met produced per minute.b Assayed in the presence of 
5 mM glutathione (GSH). 
Determination of the Km Value for Met-Gly-Met-Met.  
The strength of Met-Gly-Met-Met binding to the active site of MetAP (Km) was determined for both Fe(II)− and 
Co(II)−MetAP. Metal-substituted MetAP samples were prepared by adding 3 equiv of the appropriate divalent 
metal ion to a 20 μM buffered solution of apo-MetAP, and the mixture was incubated at 30 °C for 30 min. The 
initial rates of hydrolysis of Met-Gly-Met-Met were monitored as a function of Gly-Met-Met concentration in 25 
mM Hepes buffer (pH 7.5) and 150 mM KCl. Triplicate activity assay determinations at six concentrations of Met-
Gly-Met-Met (0−12 mM) were made, and the results are shown in Figure 4 as a plot of 1/V versus 1/[S]. From 
fits of these data, the Michaelis constant (Km) for Met-Gly-Met-Met binding to Co(II)−MetAP (▪) was determined 
to be 3.16 ± 0.34 mM, and for Fe(II)−MetAP (·), the Km was found to be 1.95 ± 0.44 mM. Combination of these 
data with kcat values for Co(II)− and Fe(II)−MetAP provides the catalytic efficiencies (kcat/Km) of each enzyme 
which are 350 ± 40 and 410 ± 40 mM-1 min-1, respectively. 
 
Figure 4 Plot of velocity vs substrate (Met-Gly-Met-Met) concentration for Co(II)−MetAP (▪) and Fe(II)−MetAP (·). 
The lines result from a fit of the entire data set for each metal-substituted MetAP enzyme to the 
Michaelis−Menten equation. All assays were performed under strict anaerobic conditions in an inert 
atmosphere glovebox in a dry bath incubator maintained at 30 °C. All enzyme and substrate stock solutions were 
prepared anaerobically in 25 mM Hepes buffer (pH 7.5) containing 150 mM KCl. 
 
Discussion 
Until recently, all MetAPs studied to date had been reported to be cobalt-dependent metalloproteases (3, 5, 7). 
However, Walker and Bradshaw have suggested that the type I MetAP from yeast is a Zn(II)-dependent enzyme 
(28). Several Zn(II)-containing metalloproteases with active site ligands similar to those of MetAPs can be 
substituted with Co(II) in vitro, and in nearly all cases, active and even hyperactive enzymes are obtained (29, 
30). The previous conclusion that MetAPs are cobalt-dependent enzymes arose from the reproducible 
observation that MetAPs exhibit high activity in the presence of cobalt when compared to the activity levels of 
other metal ions. However, the identity of the metal ion in vivo has not been established, and in all studies to 
date, Co(II) concentrations were artificially increased to the millimolar range during purification. To gain insight 
into the identification of the in vivo metal ions for the MetAP from E. coli, we examined the metal content and 
enzymatic activities of whole cell extracts in the absence and presence of MetAP expression. 
Since the MetAP from E. coli is overexpressed at high levels, any change in cellular metal content should reflect 
the divalent metal ion coordinated to MetAP. The only significant increases in cellular metal ion concentrations 
were observed for chromium, zinc, manganese, and iron. The increase in iron concentration was 4.4 and 6.2 
times greater than that in either manganese and zinc, respectively (Table 1). The cellular cobalt concentration 
did not change upon overexpression of MetAP (Table 1), suggesting that either MetAP is expressed in the apo 
form or cobalt is not the in vivo metal ion for the MetAP from E. coli. Whole cell extracts from cells where 
MetAP was overexpressed exhibited reproducibly detectable enzymatic activity (>2 units/mg), while no activity 
was detected in whole cell extracts without MetAP overexpression. These data indicate that cobalt is not 
coordinated to MetAP upon overexpression. Since MetAP is active upon expression, these data strongly suggest 
that cobalt is not the in vivo metal ion for the MetAP from E. coli. On the basis of whole cell metal analyses, 
manganese, iron, and zinc are the most likely candidates for the in vivo metal ion of MetAP. 
The MetAP from E. coli is only active toward tripeptides or larger substrates (17), so commercially available l-
amino acid−p-nitroanilide and −p-nitrophenol substrates were not cleaved. Therefore, an HPLC method was 
developed to directly detect the major product of hydrolysis, Gly-Met- Met. This has allowed us to routinely and 
accurately measure the specific activity of purified MetAP. The specific activity of Co(II)−MetAP was typically 
found to be 37.3 units per mg of enzyme, more than 3 times the level reported by Ben-Bassat et al. (11.3 
units/mg) (17). An interesting finding in this study is the fact that the Co(II) ions in MetAP are susceptible to 
autoxidation at pH 7.5 and are oxidized to the Co(III) form upon prolonged exposure to air. On the other hand, 
the Fe(II)−MetAP enzyme is oxidized to the Fe(III) form rapidly upon exposure to air. On the basis of our results, 
both the Co(III)− and Fe(III)−MetAP enzymes are enzymatically inactive. The lack of activity for Co(III)-bound 
MetAP is not surprising since Co(III) ions are kinetically inert (29, 30). Similarly, Fe(III) ions form very 
thermodynamically stable Fe(III)−hydroxide complexes so if a metal-bound hydroxide existed in Fe(III)−MetAP, it 
must be unreactive toward the hydrolysis of peptides (29). Since all of the activity measurements reported for 
MetAPs to date have been taken in air, the low levels of enzymatic activity reported for Co(II)-substituted MetAP 
are likely the result of partial oxidation of Co(II) to Co(III). Moreover, the lack of reported activity for the Fe(II)-
bound form of MetAP is likely the consequence of very rapid oxidation of Fe(II) to Fe(III) resulting in activity 
measurements being taken on the inactive Fe(III) form of MetAP. 
The reproducibility of the HPLC assay described herein has allowed us to readdress the ability of divalent cations 
to stimulate catalytic turnover for MetAP. Of the divalent metal cations tested to date, only Co(II), Fe(II), Mn(II), 
and Zn(II) provide detectable levels of enzymatic activity. In each case, excess metal ions were found to be 
inhibitory. This is similar to results reported for several different MetAPs (28). Since MetAPs are found in the 
cellular cytoplasmic space (3), activity measurements of glutathione-treated apo-MetAP enzyme that was then 
activated with either Co(II), Fe(II), or Zn(II), under anaerobic conditions, were also performed. Under these 
conditions, no detectable change in the catalytic activity was observed. The addition of 5 mM reduced 
glutathione to Co(III)− or Fe(III)−MetAP did not provide active enzyme. The observed activity levels of 
Zn(II)−MetAP were approximately 10-fold lower than those observed for Co(II)−MetAP or Fe(II)−MetAP under 
similar conditions. Zn(II) ions were recently shown to activate the type I MetAP from S. cerevisiae, in the 
presence of 5 mM glutathione (28). The role of glutathione, a cellular reductant, in the Zn(II)-substituted MetAP 
from yeast was not discussed, but it may potentially bind excess Zn(II) ions since excess Zn(II) was shown to be 
inhibitory. Alternatively, glutathione may be required to reduce active site Cys residues which are conserved for 
nearly all type I MetAPs (24). However, this alternative is less likely since no change in activity is observed for the 
MetAP from E. coli in the presence or absence of glutathione. 
The substrate binding constants (Km) for Met-Gly-Met-Met at pH 7.5 for the Co(II)− and Fe(II)−MetAP enzymes 
from E. coli were found to be 3.16 and 1.95 mM, respectively. Moreover, the catalytic efficiencies (kcat/Km) for 
Co(II)− and Fe(II)−MetAP are 350 and 410 mM-1 min-1, respectively. These data indicate that Fe(II)−MetAP is a 
better catalyst than Co(II)−MetAP. Thus, the suggestion that Fe(II) is likely the in vivo metal ion for the MetAP 
from E. coli is supported by these data since substrate binds to the Fe(II) enzyme 1.6 times more tightly than to 
the Co(II) enzyme. The Km values obtained for the MetAP from E. coli are similar to those obtained for the type I 
MetAP enzyme from yeast, assayed in the presence of 0.5 mM Co(II), which was reported to have a Km value of 
6.6 mM for Met-Gly-Met-Met (10). Moreover, the Km value for the MetAP from porcine liver, assayed in the 
presence of 0.1 mM Co(II), has been found to be in the millimolar range (31). On the other hand, the Km value of 
the human homologue of a rat initiation factor-2 associate protein (p67) was found to be 0.65 mM toward Met-
Gly-Met-Met when assayed in the presence of 0.5 mM Co(II) (22). In addition, the Km value of the type I MetAP 
enzyme from yeast toward the octapeptide Met-Ser-Ser-His-Arg-Trp-Asp-Trp was found to be 0.019 mM (28). 
Clearly, the chain length of the peptide substrate affects the strength at which substrate binds to MetAPs. 
It has been proposed that the Km values obtained for MetAPs in vitro may not be reflective of the Km value in 
vivo which may be lower due to the association of MetAP with the ribosome. Support for this hypothesis is 
provided by N-terminal extensions that include zinc finger domains in the type I MetAP enzyme from yeast (10) 
and stretches of highly charged amino acids at the N-terminal region of the type II MetAP enzyme from yeast, 
and the human homologue of rat p67 (22). These N-terminal extensions have been proposed to assist in the 
association of these MetAPs with the ribosome where they are positioned to perform N-terminal methionine 
processing on nascent peptides emerging from the ribosome. The MetAP from E. coli appears to lack these 
extensions, so the mode of its association with the ribosome is unclear at this time. 
The fact that (i) no cobalt ions are detected in whole cells containing overexpressed MetAP but significant iron 
was detected, (ii) MetAP activity is observed in the presence of MetAP overexpression but not in control cells, 
(iii) Fe(II)−MetAP is a better catalyst than Co(II)−MetAP, and (iv) the Fe(II) enzyme is nearly 10 times more active 
than Zn(II)-substituted MetAP suggests that Fe(II) is likely the physiologically relevant metal ion. These data 
suggest that the related enzymes, aminopeptidase P from E. coli (AMPP) and prolidase, might also be activated 
in vitro by Fe(II) ions. These three families of enzymes are related on the basis of sequence comparisons which 
show that the unusual protein fold observed in MetAPs is also observed in AMPP and prolidase (32). AMPP has 
been crystallographically characterized, revealing active site ligands that are identical to those of MetAPs and 
AMPP's active site is fully superimposable with those of MetAPs (33). Since all MetAPs and AMPPs have fully 
conserved active site ligands, similar metal ion requirements might be expected. For the AMPP from E. coli, it 
was recently shown that maximal catalytic activity was obtained in the presence of Mn(II) (34). AMPP is also 
nearly equally active in the presence of Co(II) ions but was reported to be inactive in the presence of Zn(II) and 
Fe(II). No structural data are currently available for prolidase, but catalytic activity measurements show that the 
prolidase from P. furiosus is activated by Co(II) and Mn(II) but not by Fe(II) or Zn(II) (35). However, all of the 
enzymatic activity measurements for both AMPP and prolidase were performed aerobically, so it is likely that 
the Fe(II) and possibly Co(II) ions had fully or partially oxidized to inactive Fe(III) and Co(III) forms, respectively. 
Additional studies with AMPP and prolidase performed under anaerobic conditions with the Fe(II) forms of the 
enzymes are needed to fully compare activities between these three families of enzymes. 
In conclusion, the combination of whole cell metal analyses and activity measurements with in vitro activity 
measurements and substrate binding constants strongly suggests that the MetAP from E. coli is an Fe(II) enzyme. 
Moreover, iron is the most prevalent cellular metal ion, and MetAPs are found in the cytoplasm where 
conditions are highly reducing. The catalytic activity of MetAPs in the presence of Fe(II) has not been previously 
observed because all activity measurements performed on MetAPs to date have been taken under aerobic 
conditions, causing the Fe(II) ions to quickly oxidize to the inactive Fe(III) form. Hydrolytic enzymes that utilize 
Fe(II) ions for catalytic activity are not particularly uncommon. The peptide deformylase from E. coli, which is the 
enzyme prior to the MetAP in the methionine cycle, has also been shown to be an Fe(II) enzyme (36). Since the 
cellular functions of these enzymes are tied to one another, Fe(II) may play a cellular regulatory role in protein 
maturation. Other examples of iron-containing hydrolases include the purple acid phosphatases and the protein 
phosphatases 2B such as calcineurin (37). In addition, several non-heme diiron enzymes, including methane 
monooxygenase, ribonucleotide reductase, and rubrerythrin, have been crystallographically characterized and 
exhibit active site structures remarkably similar to the MetAP from E. coli (38−40). Since MetAPs appear to be 
angiogenic drug targets, characterization of the in vivo metal ion and the catalytic mechanism is critical for the 
future development of new anti-cancer drugs. Studies that address the roles of each Fe(II) atom in catalysis are 
currently underway in our laboratory. 
Acknowledgment 
The methionyl aminopeptidase from E. coli was purified from a stock culture kindly provided by Drs. Brian 
Matthews and W. Todd Lowther. We also thank Drs. Ralph Bradshaw and Kenneth Walker for helpful discussions 
as well as Dr. Bradley S. Davidson for the use of his HPLC system and Drs. Duane C. Rieber and Robert S. Brown 
for mass spectrometric analysis. 
References 
1 Bradshaw, R. A. (1989) Trends Biochem. Sci.14, 276−279. 
2 Meinnel, T., Mechulam, Y., and Blanquet, S. (1993) Biochimie75, 1061−1075. 
3 Bradshaw, R. A., Brickey, W. W., and Walker, K. W. (1998) Trends Biochem. Sci.23, 263−267. 
4 Arfin, S. M., and Bradshaw, R. A. (1988) Biochemistry27, 7979−7984. 
5 Barrett, A. J., Rawlings, N. D., and Woessner, J. F. (1998) in Handbook of Proteolytic Enzymes (Barrett, A. J., 
Rawlings, N. D., and Woessner, J. F., Eds.) pp 1−1666, Academic Press, London. 
6 Boissel, J.-P., Kasper, T. J., and Bunn, H. F. (1988) J. Biol. Chem.263, 8443−8449. 
7 Taylor, A. (1996) in Aminopeptidases (Taylor, A., Ed.) pp 1−219, R. G. Landes Co., Austin, TX. 
8 Chang, S.-Y. P., McGary, E. C., and Chang, S. (1989) J. Bacteriol.171, 4071−4072. 
9 Miller, C. G., Kukral, A. M., Miller, J. L., and Movva, N. R. (1989) J. Bacteriol.171, 5215−5217. 
10 Zuo, S., Guo, Q., Ling, C., and Chang, Y.-H. (1995) Mol. Gen. Genet.246, 247−253. 
11 Taunton, J. (1997) Chem. Biol.4, 493−496. 
12 Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y.-H., Wu, Z., Biemann, K., and Liu, J. O. (1997) Chem. Biol.4, 
461−471. 
13 Sin, N., Meng, L., Wang, M. Q., Wen, J. J., Bornmann, W. G., and Crews, C. M. (1997) Proc. Natl. Acad. Sci. 
U.S.A.94, 6099−6103. 
14 Lowther, W. T., McMillen, D. A., Orville, A. M., and Matthews, B. W. (1998) Proc. Natl. Acad. Sci. U.S.A.95, 
12153−12157. 
15 Liu, S., Windom, J., Kemp, C. W., Crews, C. M., and Clardy, J. (1998) Science282, 1324−1327. 
16 Arfin, S. M., Kendall, R. L., Hall, L., Weaver, L. H., Stewart, A. E., Matthews, B. W., and Bradshaw, R. A. 
(1995) Proc. Natl. Acad. Sci. U.S.A.92, 7714−7718. 
17 Ben-Bassat, A., Bauer, K., Chang, S.-Y., Myambo, K., Boosman, A., and Chang, S. (1987) J. Bacteriol.169, 
751−757. 
18 Chang, Y.-H., Teichert, U., and Smith, J. A. (1990) J. Biol. Chem.265, 19892−19897. 
19 Chang, Y.-H., Teichert, U., and Smith, J. A. (1992) J. Biol. Chem.267, 8007−8011. 
20 Wingfield, P., Graber, P., Turcatti, G., Movva, N. R., Pelletier, M., Craig, S., Rose, K., and Miller, C. G. 
(1989) Eur. Biol. Chem.180, 23−32. 
21 Tsunasawa, S., Yukiko, I., Miyagi, M., and Kato, I. (1997) J. Biochem.122, 843−850. 
22 Li, X., and Chang, Y.-H. (1996) Biochem. Biophys. Res. Commun.227, 152−159. 
23 Roderick, S. L., and Matthews, B. W. (1993) Biochemistry32, 3907−3912. 
24 Tahirov, T. H., Oki, H., Tsukihara, T., Ogasahara, K., Yutani, K., Ogata, K., Izu, Y., Tsunasawa, S., and Kato, I. 
(1998) J. Mol. Biol.284, 101−124. 
25 Lowther, W. T., Orville, A. M., Madden, D. T., Lim, S., Rich, D. H., and Matthews, B. W. (1999) Biochemistry38, 
7678−7688. 
26 Gill, S. C., and von Hippel, P. H. (1989) Anal. Biochem.182, 319−326. 
27 Edelhoch, H. (1967) Biochemistry6, 1948−1954. 
28 Walker, K. W., and Bradshaw, R. A. (1998) Protein Sci.7, 2684−2687. 
29 Holm, R. H., Kennepohl, P., and Solomon, E. I. (1996) Chem. Rev.96, 2239−2314. 
30 Bertini, I., and Luchinat, C. (1984) Adv. Inorg. Biochem.6, 71−111. 
31 Kendall, R. L., and Bradshaw, R. A. (1992) J. Biol. Chem.267, 20667−20673. 
32 Bazan, J. F., Weaver, L. H., Roderick, S. L., Huber, R., and Matthews, B. W. (1994) Proc. Natl. Acad. Sci. 
U.S.A.91, 2473−2477. 
33 Wilce, M. C., Bond, C. S., Dixon, N. E., Freeman, H. C., Guss, J. M., Lilley, P. E., and Wilce, J. A. (1998) Proc. 
Natl. Acad. Sci. U.S.A.95, 3472−3477. 
34 Zhang, L., Crossley, M. J., Dixon, N. E., Ellis, P. J., Fisher, M. L., King, G. F., Lilley, P. E., MacLachlan, D., Pace, R. 
J., and Freeman, H. C. (1998) JBIC, J. Biol. Inorg. Chem.3, 470−483. 
35 Ghosh, M., Grunden, A. M., Dunn, D. M., Weiss, R., and Adams, M. W. W. (1998) J. Bacteriol.180, 4781−4789. 
36 Rajagopalan, P. T. R., Yu, X. C., and Pei, D. (1997) J. Am. Chem. Soc.119, 12418−12419. 
37 Wilcox, D. E. (1996) Chem. Rev.96, 2435−2458. 
38 deMare, F., Kurtz, D. M., and Nordland, P. (1996) Nat. Struct. Biol.3, 539−546. 
39 Rosenzweig, A. C., Federick, C. A., Lippard, S. J., and Nordlund, P. (1993) Nature366, 537−543. 
40 Norland, P., Sjöberg, B.-M., and Eklund, H. (1990) Nature345, 593−598. 
 
1 Abbreviations:  MetAP, methionyl aminopeptidase; AMPP, aminopeptidase P; Hepes, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid; IPTG, isopropyl β-d-thiogalactoside; TFA, trifluoroacetic acid; PMSF, 
phenylmethanesulfonyl fluoride; ICP, inductively coupled plasma; v, velocity; Vmax, maximal velocity; Km, 
Michaelis constant; [S], substrate concentration. 
 
